Austria and Co. buy 1.25 million Valneva cans
Austria, Germany, Denmark, Finland and Bulgaria are buying a total of 1.25 million doses of the dead vaccine from the Austro-French manufacturer Valneva this year.
This was confirmed by the signing of the amendment to the pre-purchase agreement with the European Commission on Monday, Valneva announced on Monday evening. The company expects the first doses of vaccine to be delivered to participating EU member states in the coming weeks.
The massive cut in the contract had already been announced on July 20th. The opt-out period for the member states has now expired, the broadcast said. Under the amendment, member states will purchase 1.25 million doses of Valneva’s alleged inactivated vaccine in 2022, with the option to later purchase the same amount for delivery in 2022.
Originally planned for many more cans
Originally, the delivery of 60 million doses was agreed, of which around 27 million were planned for this year. However, delays in the approval process and shorter vaccine demand caused by vaccine oversupply and a slowdown in immunization prompted EU countries to seek amendments to the original treaty.
The VLA2001 called vaccine was only approved in the EU on June 24th. The European Medicines Agency (EMA) had previously recommended the vaccine for use as a primary vaccine in people aged 18 to 50. In the European Union, it is the sixth approved Covid 19 vaccine and the first so-called dead vaccine.
Vaccine developed in Vienna
Valneva’s Covid vaccine is the only whole-virus (‘dead vaccine’) vaccine developed in Europe. Valneva took an approach that has been tried and tested for many years. All of the dead virus WILL be presented to the body. Thus, the immune system has to deal with all parts of the pathogen. Production takes place in Scotland and Sweden, but according to the company, most of the development work was done via Vienna. VLA2001 is also approved in the UK and Bahrain and the United Arab Emirates.